154 related articles for article (PubMed ID: 7681913)
21. Effects of intravenous nifekalant, a class III antiarrhythmic drug, on atrial vulnerability parameters in patients with paroxysmal atrial fibrillation.
Minami T; Isomoto S; Nakao K; Komiya N; Fukae S; Centurion OA; Yano K
Pacing Clin Electrophysiol; 2004 Feb; 27(2):212-7. PubMed ID: 14764172
[TBL] [Abstract][Full Text] [Related]
22. Effects of a novel class III antiarrhythmic agent, NIP-142, on canine atrial fibrillation and flutter.
Nagasawa H; Fujiki A; Fujikura N; Matsuda T; Yamashita T; Inoue H
Circ J; 2002 Feb; 66(2):185-91. PubMed ID: 11999646
[TBL] [Abstract][Full Text] [Related]
23. Onset of induced atrial flutter in the canine pericarditis model.
Shimizu A; Nozaki A; Rudy Y; Waldo AL
J Am Coll Cardiol; 1991 Apr; 17(5):1223-34. PubMed ID: 2007723
[TBL] [Abstract][Full Text] [Related]
24. Antiarrhythmic and electrophysiologic effects of ibutilide in a chronic canine model of atrial flutter.
Buchanan LV; Turcotte UM; Kabell GG; Gibson JK
J Cardiovasc Pharmacol; 1993 Jul; 22(1):10-4. PubMed ID: 7690080
[TBL] [Abstract][Full Text] [Related]
25. Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy.
Cha Y; Wales A; Wolf P; Shahrokni S; Sawhney N; Feld GK
J Cardiovasc Electrophysiol; 1996 Sep; 7(9):809-27. PubMed ID: 8884510
[TBL] [Abstract][Full Text] [Related]
26. Effects of pentisomide and E-4031 on canine atrial flutter due to reentry: a comparative study with disopyramide and propafenone.
Inoue H; Yamashita T; Usui M; Nozaki A; Saihara S; Sugimoto T
J Cardiovasc Pharmacol; 1991 Jul; 18(1):137-43. PubMed ID: 1719282
[TBL] [Abstract][Full Text] [Related]
27. Electrophysiological effects of a new class III antiarrhythmic agent (E-4031) on the conduction and refractoriness of the in vivo human atrium.
Shimizu A; Fukatani M; Konoe A; Isomoto S; Centurion OA; Yano K
Cardiovasc Res; 1993 Jul; 27(7):1333-8. PubMed ID: 8252596
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiologic effects and efficacy of cibenzoline on stimulation-induced atrial fibrillation and flutter and implications for treatment of paroxysmal atrial fibrillation.
Kühlkamp V; Meerhof J; Schmidt F; Mayer F; Ickrath O; Haasis R; Seipel L
Am J Cardiol; 1990 Mar; 65(9):628-32. PubMed ID: 2309633
[TBL] [Abstract][Full Text] [Related]
29. Influence of propafenone on resetting and termination of canine atrial flutter.
Mensour B; Jalil E; Vinet A; Kus T
Pacing Clin Electrophysiol; 2000 Aug; 23(8):1200-19. PubMed ID: 10962741
[TBL] [Abstract][Full Text] [Related]
30. Rate-dependent effects of the class III antiarrhythmic drug almokalant on refractoriness in the pig.
Wiesfeld AC; De Langen CD; Crijns HJ; Bel KJ; Hillege HL; Wesseling H; Lie KI
J Cardiovasc Pharmacol; 1996 Apr; 27(4):594-600. PubMed ID: 8847879
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of spontaneous termination of stable atrial flutter in the canine sterile pericarditis model.
Ortiz J; Igarashi M; Gonzalez HX; Laurita K; Rudy Y; Waldo AL
Circulation; 1993 Oct; 88(4 Pt 1):1866-77. PubMed ID: 8403332
[TBL] [Abstract][Full Text] [Related]
32. Termination of a tachyarrhythmia by flunarizine is not a specific marker for a triggered mechanism.
Vitebskiy SA; Khrestian CM; Waldo AL
Heart Rhythm; 2007 Dec; 4(12):1544-52. PubMed ID: 17974494
[TBL] [Abstract][Full Text] [Related]
33. Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias.
Ryu K; Li L; Khrestian CM; Matsumoto N; Sahadevan J; Ruehr ML; Van Wagoner DR; Efimov IR; Waldo AL
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1231-41. PubMed ID: 17434983
[TBL] [Abstract][Full Text] [Related]
34. Electrophysiologic mechanism of typical atrial flutter termination by nifekalant: effect of a pure IKr -selective blocking agent.
Yamabe H; Tanaka Y; Morihisa K; Uemura T; Koyama J; Kanazawa H; Hoshiyama T; Ogawa H
Pacing Clin Electrophysiol; 2013 Sep; 36(9):1123-31. PubMed ID: 23607491
[TBL] [Abstract][Full Text] [Related]
35. Vanoxerine, a new drug for terminating atrial fibrillation and flutter.
Matsumoto N; Khrestian CM; Ryu K; Lacerda AE; Brown AM; Waldo AL
J Cardiovasc Electrophysiol; 2010 Mar; 21(3):311-9. PubMed ID: 19817929
[TBL] [Abstract][Full Text] [Related]
36. Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model.
Restivo M; Hegazy M; Caref EB; Avitable MJ; Assadi MA; el-Hamami M; Yin H; Piracha M; Brooks RR; el-Sherif N
J Cardiovasc Electrophysiol; 1996 Jul; 7(7):612-24. PubMed ID: 8807407
[TBL] [Abstract][Full Text] [Related]
37. Activation patterns in experimental canine atrial flutter produced by right atrial crush injury.
Feld GK; Shahandeh-Rad F
J Am Coll Cardiol; 1992 Aug; 20(2):441-51. PubMed ID: 1634684
[TBL] [Abstract][Full Text] [Related]
38. Is the acetylcholine-regulated inwardly rectifying potassium current a viable antiarrhythmic target? Translational discrepancies of AZD2927 and A7071 in dogs and humans.
Walfridsson H; Anfinsen OG; Berggren A; Frison L; Jensen S; Linhardt G; Nordkam AC; Sundqvist M; Carlsson L
Europace; 2015 Mar; 17(3):473-82. PubMed ID: 25082948
[TBL] [Abstract][Full Text] [Related]
39. Electrophysiological effects of a new antiarrhythmic agent, flecainide, on the intact canine heart.
Hodess AB; Follansbee WP; Spear JF; Moore EN
J Cardiovasc Pharmacol; 1979; 1(4):427-39. PubMed ID: 94620
[TBL] [Abstract][Full Text] [Related]
40. Effects of Cilazapril on atrial electrical, structural and functional remodeling in atrial fibrillation dogs.
Li Y; Li W; Yang B; Han W; Dong D; Xue J; Li B; Yang S; Sheng L
J Electrocardiol; 2007 Jan; 40(1):100.e1-6. PubMed ID: 17067622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
